Repare Therapeutics
RPTX
#9324
Rank
โ‚ฌ80.4 M
Marketcap
1,87ย โ‚ฌ
Share price
1.16%
Change (1 day)
-35.84%
Change (1 year)

Revenue for Repare Therapeutics (RPTX)

Revenue in 2025 (TTM): โ‚ฌ0.21 Million

According to Repare Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.21 Million. In 2024 the company made a revenue of โ‚ฌ51.38 Million an increase over the revenue in the year 2023 that were of โ‚ฌ46.25 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Repare Therapeutics from 2019 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.21 M-99.59%
2024 โ‚ฌ51.38 M11.1%
2023 โ‚ฌ46.25 M-62.36%
2022 โ‚ฌ0.12 B1731.35%
2021 โ‚ฌ6.71 M6014.23%
2020 โ‚ฌ0.1 M
2019 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA